The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Edward J. Gane

New Zealand Liver Transplant Unit

Auckland City Hospital

Auckland

New Zealand

[email]@*.govt.nz

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • New Zealand Liver Transplant Unit, Auckland City Hospital, Auckland, New Zealand. 2007 - 2013
  • Auckland Clinical Studies, Auckland, New Zealand. 2010

References

  1. Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C. Gane, E.J., Stedman, C.A., Hyland, R.H., Ding, X., Svarovskaia, E., Symonds, W.T., Hindes, R.G., Berrey, M.M. N. Engl. J. Med. (2013) [Pubmed]
  2. Future perspectives: towards interferon-free regimens for HCV. Gane, E. Antivir. Ther. (Lond.) (2012) [Pubmed]
  3. Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B. Gane, E.J., Wang, Y., Liaw, Y.F., Hou, J., Thongsawat, S., Wan, M., Moon, Y.M., Jia, J., Chao, Y.C., Niu, J., Leung, N., Samuel, D., Hsu, C.W., Bao, W., Lopez, P., Avila, C. Liver Int. (2011) [Pubmed]
  4. Future hepatitis C virus treatment: interferon-sparing combinations. Gane, E. Liver Int. (2011) [Pubmed]
  5. Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial. Gane, E.J., Roberts, S.K., Stedman, C.A., Angus, P.W., Ritchie, B., Elston, R., Ipe, D., Morcos, P.N., Baher, L., Najera, I., Chu, T., Lopatin, U., Berrey, M.M., Bradford, W., Laughlin, M., Shulman, N.S., Smith, P.F. Lancet (2010) [Pubmed]
  6. The mitochondria-targeted anti-oxidant mitoquinone decreases liver damage in a phase II study of hepatitis C patients. Gane, E.J., Weilert, F., Orr, D.W., Keogh, G.F., Gibson, M., Lockhart, M.M., Frampton, C.M., Taylor, K.M., Smith, R.A., Murphy, M.P. Liver Int. (2010) [Pubmed]
  7. The Roadmap concept: using early on-treatment virologic responses to optimize long-term outcomes for patients with chronic hepatitis B. Gane, E.J. Hepatol. Int (2008) [Pubmed]
  8. The natural history of recurrent hepatitis C and what influences this. Gane, E.J. Liver Transpl. (2008) [Pubmed]
  9. Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation. Gane, E.J., Angus, P.W., Strasser, S., Crawford, D.H., Ring, J., Jeffrey, G.P., McCaughan, G.W. Gastroenterology (2007) [Pubmed]
 
WikiGenes - Universities